The molecular world is full of surprises, and none more stunning than those occurring among the infinitesimal proteins that drive the activities guarding against viral infections and cancer.
The 'dengue belt' stretches around much of the planet crossing continents, cultures and time zones, a vast region linked by a common fate: a mosquito-borne disease that can be prevented for a select number of people with ...
How does SARS-CoV-2 evade our immune defenses? It's a good question, actually. When SARS-CoV-2 defeats host defenses, we need to know how it does so, and conversely, when host defenses prevail, that also needs to be understood. ...
A large international team of researchers has conducted a study aimed at tracing the transmission rates and the origin of major SARS-CoV-2 strains currently circulating in Brazil. In their paper published in the journal Science, ...
Over the last decade, evidence has mounted that the measles vaccine protects in not one but two ways: Not only does it prevent the well-known acute illness with spots and fever that frequently sends children to the hospital, ...
Oct 31, 2019
0
119
A chemical modification in the HIV-1 RNA genome whose function has been a matter of scientific debate is now confirmed to be key to the virus's ability to survive and thrive after infecting host cells, a new study has found.
Apr 11, 2024
0
36
As lung cells are killed by the influenza virus, they burst open, releasing molecular signals that trigger the immune cells that can combat the infection. This strategy can be an important red flag that something is wrong; ...
Apr 10, 2024
0
20
A newly developed intranasal vaccine candidate helps to clear COVID-19 infections more quickly than controls in pre-clinical testing, according to a recent study. The new vaccine platform relies on a protein scaffold that ...
Mar 13, 2024
0
89
Scientists from Duke-NUS Medical School (Duke-NUS) have developed a new approach using the Zika virus to destroy brain cancer cells and inhibit tumor growth, while sparing healthy cells. Using Zika virus vaccine candidates ...
Mar 8, 2024
0
132
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some ...
Mar 7, 2024
0
597
